Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Upcoming patient data

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Feb 19, 2022 9:20am

191 Views

Post# 34444658

RE:RE:Upcoming patient data

I respectfully disagree Oil, we don't want to be some kind of fad that is vulnerable to big swings because those situations very seldom benefit investors like us.

When the numbers come in and assuming they are as we expect they will speak for themselves and we will be rewarded.

Oilminerdeluxe wrote: 83 M market cap. I will never understand markets. It's getting really close to the next update. Should be a lot of data in it. Maybe we should change name to Theralase Crypto instead.

<< Previous

Bullboard Posts

Next >>

Revolutionizing medical imaging with nanocarbon-based contrast drugs